Product Code Database
Example Keywords: belt -jeans $100
   » » Wiki: Nicholas Lydon
Tag Wiki 'Nicholas Lydon'.
Tag

Nicholas Lydon
 (

 C O N T E N T S 
Rank: 100%
Bluestar Bluestar Bluestar Bluestar Blackstar

Nicholas B. Lydon (born 27 February 1957) is a British scientist and entrepreneur. In 2009, he was awarded the and in 2012 the for the development of , also known as Imatinib, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukaemia (CML), which converted a fatal cancer into a manageable chronic condition.


Education
Lydon was educated at Strathallan School near Perth, . He earned a Bachelor of Science degree in from the University of Leeds, in 1978 and received his PhD in biochemistry from the University of Dundee, Scotland in 1982.


Career
In 1982, Lydon accepted a position with based in as Chargé de Récherche. Three years later, he moved to Switzerland to work with , with whom he developed Gleevec. In 1997, he established Kinetex Pharmaceuticals in Boston which was acquired by in 2000, with whom he worked until 2002. Thereafter, he established several companies that continue to develop drugs to treat various conditions.


Honours and awards
  • Warren Alpert Foundation Prize, 2000.
  • Twenty First Annual , 2002.
  • Charles F. , General Motors Cancer Research Foundation, 2002.
  • The Lasker-DeBakey Clinical Medical Research Award, with and , 2009.
  • The , with Brian Druker and , 2012.
  • Fellow of the Royal Society, 2013.
  • Royal Society GlaxoSmithKline Prize and Lecture, 2014

Lydon's nomination for the reads:

Page 1 of 1
1
Page 1 of 1
1

Account

Social:
Pages:  ..   .. 
Items:  .. 

Navigation

General: Atom Feed Atom Feed  .. 
Help:  ..   .. 
Category:  ..   .. 
Media:  ..   .. 
Posts:  ..   ..   .. 

Statistics

Page:  .. 
Summary:  .. 
1 Tags
10/10 Page Rank
5 Page Refs